Zenas BioPharma (ZBIO) Return on Assets (2024 - 2026)

Zenas BioPharma's Return on Assets history runs 3 years deep, the most recent figure standing at 0.01% for Q1 2026.

• In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
• Return on Assets was 0.01% for Q1 2026 at Zenas BioPharma, up from 0.01% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2024 to a low of 0.01% in Q4 2025.
• Historically, Return on Assets has averaged 0.01% across 3 years, with a median of 0.01% in 2025.
• The sharpest annual moves came in 2025 and 2026: Return on Assets slipped 1 bps in 2025, then changed 0 bps in 2026.
• A 3-year view of Return on Assets shows it stood at 0.0% in 2024, then sank by 165 bps to 0.01% in 2025, then soared by 30 bps to 0.01% in 2026.
• The last three Return on Assets figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.